A270210 Stock Overview

Researches, develops, produces, and sells skin care products in Korea. More details

A270210 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the KR market

Has not reported any financial data

Does not have a meaningful market cap (₩25B)

My Notes

Capture your thoughts, links and company narrative

SR biotek Inc. Competitors

Skin n Skin

KOSDAQ:A159910

₩35.7b

RifaLtd

KOSE:A000760

₩29.3b

S&K Polytec

KOSDAQ:A091340

₩27.8b

NANOCMSLtd

KOSDAQ:A247660

₩26.0b

Price History & Performance

Summary of share price highs, lows and changes for SR biotek
Historical stock prices
Current Share Price	₩20,000.00
52 Week High	₩46,000.00
52 Week Low	₩2,670.00
Beta	0
1 Month Change	-31.86%
3 Month Change	28.95%
1 Year Change	488.24%
3 Year Change	470.61%
5 Year Change	70.94%
Change since IPO	-20.00%

Recent updates

Shareholder Returns

	A270210	KR Chemicals	KR Market
7D	-4.3%	5.7%	3.4%
1Y	488.2%	-36.4%	-2.8%

Return vs Industry: A270210 exceeded the KR Chemicals industry which returned -36.4% over the past year.

Return vs Market: A270210 exceeded the KR Market which returned -2.8% over the past year.

Price Volatility

Is A270210's price volatile compared to industry and market?
A270210 volatility
A270210 Average Weekly Movement	15.6%
Chemicals Industry Average Movement	6.4%
Market Average Movement	6.5%
10% most volatile stocks in KR Market	12.9%
10% least volatile stocks in KR Market	3.3%

Stable Share Price: A270210's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A270210's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

Founded	Employees	CEO	Website
2005	n/a	n/a	srbiotek.com

SR biotek Inc. researches, develops, produces, and sells skin care products in Korea. It offers RAPHITOX, a bio material with micro needle shaped structure, which is used for healthy skin. The company also provides skin nutritive creams, anti-aging care creams, skin recovery products, oil deep cleansers, gel cleansers, essence toners, natural vita serums, cooling masks, daily moisturizing creams, intense creams, treatment masks, foam cleansers, sebum control products, whitening and moisture care products, and aloe soothing gels.

SR biotek Inc. Fundamentals Summary

How do SR biotek's earnings and revenue compare to its market cap?
A270210 fundamental statistics
Market cap	₩25.49b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A270210 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A270210 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A270210 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 21:28
End of Day Share Price	2025/02/19 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SR biotek Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Seong Man Yoo	Hyundai Motor Securities Co. Ltd.